Life Science Insights closely follows all of the key segments in the life science landscape. From the basic scientific research which builds our understanding of biological processes through drug discovery, development, clinical trials, pharmaceutical manufacturing, distribution, sales and marketing.

 

   


Life Science Insights' Top 10 Predictions for the Biopharmaceutical Industry in 2005

Analysts in the News:

LSI Analysts author article on apoptosis-targeting therapies for leading industry journal, Nature Reviews

To download article, click:

http://cdn.idc.com/prmContent/nrd1554_-_apoptosis.pdf

 

 

 

Developing the Newest Class of Therapeutics: Profile of Alnylam Pharmaceuticals' RNAi Strategy
Analysis of the Merger of DNA Sequencing Start-Ups Solexa and Lynx
U.S. Clinical Trial Management Systems 2004-2008 Forecast & Analysis

Worldwide Therapeutic RNAi 2004-2014 Forecast and Analysis

Today's CRO: Understanding Changing Requirements for Clinical Trials Outsourcing
Oracle in Clinical Trials: At a Critical Juncture
Proteomics: Protein Array Market and Technology Overview
Latest Leading Indicators from Life Science Insights: Twelve Month Spending Outlook Positive; Clinical Trials Area Leads in Optimism

Strong Clinical Trial Management Systems Market Offers Opportunities for Vendors, Clinical Sponsors, and CROs Alike, Says Life Science Insights

Life Science Insights Offers Proprietary Intelligence to Venture Capitalists and Private Equity Investors

Clinical Trials Outsourcing Poised for Growth, Life Science Insights Research Practice Reveals
Life Science Insights Announces Coverage of Life Science Technology Vendors Starting Q3 2004

Next Generation Biosurveillance Will Require High-End IT Infrastructure, Says Life Science Insights